Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The FANCA gene encodes a protein that is a core component of the Fanconi anemia (FA) pathway, which is crucial for DNA repair, specifically the repair of interstrand cross-links (ICLs). The FA pathway is activated when DNA replication stalls due to damage. FANCA forms part of the FA core complex, which monoubiquitinates FANCD2 and FANCI, recruiting downstream DNA repair machinery. Mutations in FANCA are responsible for a large proportion of Fanconi anemia cases.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fanconi anemia complementation group A (FANCA).